Iota-carrageenan extracted from red algae is a potent inhibitor of SARS-CoV-2 infection in reconstituted human airway epithelia

{ 'indexed': {'date-parts': [[2022, 5, 31]], 'date-time': '2022-05-31T23:10:34Z', 'timestamp': 1654038634868}, 'reference-count': 32, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2022, 3, 1]], 'date-time': '2022-03-01T00:00:00Z', 'timestamp': 1646092800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2021, 12, 9]], 'date-time': '2021-12-09T00:00:00Z', 'timestamp': 1639008000000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'http://creativecommons.org/licenses/by-nc-nd/4.0/'}], 'content-domain': {'domain': ['elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2022, 3]]}, 'DOI': '10.1016/j.bbrep.2021.101187', 'type': 'journal-article', 'created': { 'date-parts': [[2021, 12, 15]], 'date-time': '2021-12-15T23:07:38Z', 'timestamp': 1639609658000}, 'page': '101187', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Iota-carrageenan extracted from red algae is a potent inhibitor of SARS‐CoV-2 infection in ' 'reconstituted human airway epithelia', 'prefix': '10.1016', 'volume': '29', 'author': [ { 'ORCID': 'http://orcid.org/0000-0003-3467-1251', 'authenticated-orcid': False, 'given': 'David', 'family': 'Bovard', 'sequence': 'first', 'affiliation': []}, {'given': 'Marco', 'family': 'van der Toorn', 'sequence': 'additional', 'affiliation': []}, {'given': 'Walter K.', 'family': 'Schlage', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-0931-2663', 'authenticated-orcid': False, 'given': 'Samuel', 'family': 'Constant', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kasper', 'family': 'Renggli', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-5324-359X', 'authenticated-orcid': False, 'given': 'Manuel C.', 'family': 'Peitsch', 'sequence': 'additional', 'affiliation': []}, {'given': 'Julia', 'family': 'Hoeng', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'issue': '3', 'key': '10.1016/j.bbrep.2021.101187_bib2', 'doi-asserted-by': 'crossref', 'first-page': '141', 'DOI': '10.1038/s41579-020-00459-7', 'article-title': 'Characteristics of SARS-CoV-2 and COVID-19', 'volume': '19', 'author': 'Hu', 'year': '2021', 'journal-title': 'Nat. Rev. Microbiol.'}, { 'issue': '7', 'key': '10.1016/j.bbrep.2021.101187_bib3', 'doi-asserted-by': 'crossref', 'first-page': '102573', 'DOI': '10.1016/j.autrev.2020.102573', 'article-title': 'COVID-19 gone bad: a new character in the spectrum of the ' 'hyperferritinemic syndrome?', 'volume': '19', 'author': 'Colafrancesco', 'year': '2020', 'journal-title': 'Autoimmun. Rev.'}, { 'issue': '5', 'key': '10.1016/j.bbrep.2021.101187_bib4', 'doi-asserted-by': 'crossref', 'first-page': 'e2136', 'DOI': '10.1002/rmv.2136', 'article-title': 'Current pharmacological modalities for management of novel coronavirus ' 'disease 2019 (COVID-19) and the rationale for their utilization: a ' 'review', 'volume': '30', 'author': 'Giovane', 'year': '2020', 'journal-title': 'Rev. Med. Virol.'}, { 'issue': '18', 'key': '10.1016/j.bbrep.2021.101187_bib5', 'first-page': '1824', 'article-title': 'Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a ' 'review', 'volume': '323', 'author': 'Sanders', 'year': '2020', 'journal-title': 'Jama'}, { 'issue': '21', 'key': '10.1016/j.bbrep.2021.101187_bib6', 'doi-asserted-by': 'crossref', 'first-page': '2149', 'DOI': '10.1001/jama.2020.22813', 'article-title': 'Therapy for early COVID-19: a critical need', 'volume': '324', 'author': 'Kim', 'year': '2020', 'journal-title': 'Jama'}, { 'issue': '9', 'key': '10.1016/j.bbrep.2021.101187_bib7', 'first-page': 'Cd013627', 'article-title': 'Antimicrobial mouthwashes (gargling) and nasal sprays administered to ' 'patients with suspected or confirmed COVID-19 infection to improve ' 'patient outcomes and to protect healthcare workers treating them', 'volume': '9', 'author': 'Burton', 'year': '2020', 'journal-title': 'Cochrane Database Syst. Rev.'}, { 'issue': '2', 'key': '10.1016/j.bbrep.2021.101187_bib8', 'doi-asserted-by': 'crossref', 'first-page': '119', 'DOI': '10.2217/fmb-2020-0286', 'article-title': 'Review of the use of nasal and oral antiseptics during a global ' 'pandemic', 'volume': '16', 'author': 'Stathis', 'year': '2021', 'journal-title': 'Future Microbiol.'}, { 'issue': '2', 'key': '10.1016/j.bbrep.2021.101187_bib9', 'doi-asserted-by': 'crossref', 'first-page': '631', 'DOI': '10.1002/path.1570', 'article-title': 'Tissue distribution of ACE2 protein, the functional receptor for SARS ' 'coronavirus. A first step in understanding SARS pathogenesis', 'volume': '203', 'author': 'Hamming', 'year': '2004', 'journal-title': 'J. Pathol.'}, { 'issue': '12', 'key': '10.1016/j.bbrep.2021.101187_bib10', 'doi-asserted-by': 'crossref', 'first-page': '1177', 'DOI': '10.1056/NEJMc2001737', 'article-title': 'SARS-CoV-2 viral load in upper respiratory specimens of infected ' 'patients', 'volume': '382', 'author': 'Zou', 'year': '2020', 'journal-title': 'N. Engl. J. Med.'}, { 'key': '10.1016/j.bbrep.2021.101187_bib11', 'first-page': 'Cd013626', 'article-title': 'Use of antimicrobial mouthwashes (gargling) and nasal sprays by ' 'healthcare workers to protect them when treating patients with ' 'suspected or confirmed COVID-19 infection', 'volume': '9', 'author': 'Burton', 'year': '2020', 'journal-title': 'Cochrane Database Syst. Rev.'}, { 'issue': '1', 'key': '10.1016/j.bbrep.2021.101187_bib12', 'first-page': '28', 'article-title': 'Safety and efficacy of iota-carrageenan nasal spray in treatment and ' 'prevention of the common cold', 'volume': '94', 'author': 'Bichiri', 'year': '2021', 'journal-title': 'Med Pharm Rep'}, { 'key': '10.1016/j.bbrep.2021.101187_bib13', 'series-title': 'Carrageenan Nasal Spray May Double the Rate of Recovery from Coronavirus ' 'and Influenza Virus Infections: Re-analysis of Randomized Trial Data', 'author': 'Hemilä', 'year': '2020'}, { 'issue': '2', 'key': '10.1016/j.bbrep.2021.101187_bib14', 'doi-asserted-by': 'crossref', 'first-page': 'e0237480', 'DOI': '10.1371/journal.pone.0237480', 'article-title': 'Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication ' 'in vitro', 'volume': '16', 'author': 'Morokutti-Kurz', 'year': '2021', 'journal-title': 'PLoS One'}, { 'issue': '12', 'key': '10.1016/j.bbrep.2021.101187_bib15', 'doi-asserted-by': 'crossref', 'first-page': 'e14320', 'DOI': '10.1371/journal.pone.0014320', 'article-title': 'Iota-carrageenan is a potent inhibitor of influenza A virus infection', 'volume': '5', 'author': 'Leibbrandt', 'year': '2010', 'journal-title': 'PLoS One'}, { 'key': '10.1016/j.bbrep.2021.101187_bib16', 'doi-asserted-by': 'crossref', 'first-page': '107', 'DOI': '10.1186/1743-422X-5-107', 'article-title': 'Iota-Carrageenan is a potent inhibitor of rhinovirus infection', 'volume': '5', 'author': 'Grassauer', 'year': '2008', 'journal-title': 'Virol. J.'}, { 'issue': '1', 'key': '10.1016/j.bbrep.2021.101187_bib17', 'doi-asserted-by': 'crossref', 'first-page': '108', 'DOI': '10.1186/1465-9921-11-108', 'article-title': 'Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a ' 'randomized, double-blind, placebo-controlled exploratory study in ' 'volunteers with early symptoms of the common cold', 'volume': '11', 'author': 'Eccles', 'year': '2010', 'journal-title': 'Respir. Res.'}, { 'key': '10.1016/j.bbrep.2021.101187_bib18', 'doi-asserted-by': 'crossref', 'first-page': '147', 'DOI': '10.1186/1472-6882-12-147', 'article-title': 'Lessons learned from a double-blind randomised placebo-controlled study ' 'with a iota-carrageenan nasal spray as medical device in children with ' 'acute symptoms of common cold', 'volume': '12', 'author': 'Fazekas', 'year': '2012', 'journal-title': 'BMC Compl. Alternative Med.'}, { 'issue': '1', 'key': '10.1016/j.bbrep.2021.101187_bib19', 'doi-asserted-by': 'crossref', 'first-page': '124', 'DOI': '10.1186/1465-9921-14-124', 'article-title': 'Efficacy of a carrageenan nasal spray in patients with common cold: a ' 'randomized controlled trial', 'volume': '14', 'author': 'Ludwig', 'year': '2013', 'journal-title': 'Respir. Res.'}, { 'issue': '1', 'key': '10.1016/j.bbrep.2021.101187_bib20', 'doi-asserted-by': 'crossref', 'first-page': '57', 'DOI': '10.1186/2049-6958-9-57', 'article-title': 'Carrageenan nasal spray in virus confirmed common cold: individual ' 'patient data analysis of two randomized controlled trials', 'volume': '9', 'author': 'Koenighofer', 'year': '2014', 'journal-title': 'Multidiscip Respir Med'}, { 'key': '10.1016/j.bbrep.2021.101187_bib21', 'doi-asserted-by': 'crossref', 'first-page': '53', 'DOI': '10.2147/IJGM.S120665', 'article-title': 'Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or ' 'carrageenan lozenges as active treatments for sore throat', 'volume': '10', 'author': 'Morokutti-Kurz', 'year': '2017', 'journal-title': 'Int. J. Gen. Med.'}, { 'key': '10.1016/j.bbrep.2021.101187_bib22', 'doi-asserted-by': 'crossref', 'first-page': '110110', 'DOI': '10.1016/j.mehy.2020.110110', 'article-title': 'Inhaled hydroxychloroquine to improve efficacy and reduce harm in the ' 'treatment of COVID-19', 'volume': '143', 'author': 'Kavanagh', 'year': '2020', 'journal-title': 'Med. Hypotheses'}, { 'issue': '24', 'key': '10.1016/j.bbrep.2021.101187_bib23', 'doi-asserted-by': 'crossref', 'first-page': '3814', 'DOI': '10.1039/C8LC01029C', 'article-title': 'A lung/liver-on-a-chip platform for acute and chronic toxicity studies', 'volume': '18', 'author': 'Bovard', 'year': '2018', 'journal-title': 'Lab Chip'}, { 'key': '10.1016/j.bbrep.2021.101187_bib24', 'doi-asserted-by': 'crossref', 'first-page': '56', 'DOI': '10.1016/j.crtox.2020.08.002', 'article-title': 'Comparison of the basic morphology and function of 3D lung epithelial ' 'cultures derived from several donors', 'volume': '1', 'author': 'Bovard', 'year': '2020', 'journal-title': 'Current Research in Toxicology'}, { 'key': '10.1016/j.bbrep.2021.101187_bib25', 'series-title': 'Drug Discovery and Development - Present and Future', 'first-page': '169', 'article-title': 'The use of in vitro 3D cell models in drug development for respiratory ' 'diseases', 'author': 'Huang', 'year': '2011'}, { 'key': '10.1016/j.bbrep.2021.101187_bib26', 'doi-asserted-by': 'crossref', 'article-title': '3-D nasal cultures: systems toxicological assessment of a candidate ' 'modified-risk tobacco product', 'author': 'Iskandar', 'year': '2016', 'journal-title': 'ALTEX', 'DOI': '10.14573/altex.1605041s'}, { 'issue': '4', 'key': '10.1016/j.bbrep.2021.101187_bib27', 'doi-asserted-by': 'crossref', 'first-page': '100059', 'DOI': '10.1016/j.xcrm.2020.100059', 'article-title': 'Characterization and treatment of SARS-CoV-2 in nasal and bronchial ' 'human airway epithelia', 'volume': '1', 'author': 'Pizzorno', 'year': '2020', 'journal-title': 'Cell Rep Med'}, { 'issue': '5', 'key': '10.1016/j.bbrep.2021.101187_bib28', 'doi-asserted-by': 'crossref', 'first-page': '864', 'DOI': '10.1016/j.tiv.2015.03.004', 'article-title': 'Targeted omics analyses, and metabolic enzyme activity assays ' 'demonstrate maintenance of key mucociliary characteristics in long term ' 'cultures of reconstituted human airway epithelia', 'volume': '29', 'author': 'Baxter', 'year': '2015', 'journal-title': 'Toxicol. Vitro'}, { 'issue': '12', 'key': '10.1016/j.bbrep.2021.101187_bib29', 'doi-asserted-by': 'crossref', 'DOI': '10.3390/v12121425', 'article-title': 'Leveraging 3D model systems to understand viral interactions with the ' 'respiratory mucosa', 'volume': '12', 'author': 'Iverson', 'year': '2020', 'journal-title': 'Viruses'}, { 'key': '10.1016/j.bbrep.2021.101187_bib30', 'doi-asserted-by': 'crossref', 'first-page': '32', 'DOI': '10.1186/1743-8977-6-32', 'article-title': 'A dose-controlled system for air-liquid interface cell exposure and ' 'application to zinc oxide nanoparticles', 'volume': '6', 'author': 'Lenz', 'year': '2009', 'journal-title': 'Part. Fibre Toxicol.'}, { 'issue': '2', 'key': '10.1016/j.bbrep.2021.101187_bib31', 'doi-asserted-by': 'crossref', 'first-page': '107', 'DOI': '10.1177/2211068214561025', 'article-title': 'TEER measurement techniques for in vitro barrier model systems', 'volume': '20', 'author': 'Srinivasan', 'year': '2015', 'journal-title': 'J. Lab. Autom.'}, { 'key': '10.1016/j.bbrep.2021.101187_bib32', 'doi-asserted-by': 'crossref', 'first-page': '275', 'DOI': '10.2147/IJGM.S167123', 'article-title': 'Development of a nasal spray containing xylometazoline hydrochloride ' 'and iota-carrageenan for the symptomatic relief of nasal congestion ' 'caused by rhinitis and sinusitis', 'volume': '11', 'author': 'Graf', 'year': '2018', 'journal-title': 'Int. J. Gen. Med.'}, { 'issue': '5', 'key': '10.1016/j.bbrep.2021.101187_bib33', 'doi-asserted-by': 'crossref', 'first-page': 'L750', 'DOI': '10.1152/ajplung.00552.2020', 'article-title': 'Carrageenan-containing over-the-counter nasal and oral sprays inhibit ' 'SARS-CoV-2 infection of airway epithelial cultures', 'volume': '320', 'author': 'Schütz', 'year': '2021', 'journal-title': 'Am. J. Physiol. Lung Cell Mol. Physiol.'}], 'container-title': 'Biochemistry and Biophysics Reports', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S2405580821002818?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S2405580821002818?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2022, 5, 31]], 'date-time': '2022-05-31T22:51:55Z', 'timestamp': 1654037515000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S2405580821002818'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 3]]}, 'references-count': 32, 'alternative-id': ['S2405580821002818'], 'URL': 'http://dx.doi.org/10.1016/j.bbrep.2021.101187', 'relation': {}, 'ISSN': ['2405-5808'], 'subject': ['Biochemistry', 'Biophysics'], 'container-title-short': 'Biochemistry and Biophysics Reports', 'published': {'date-parts': [[2022, 3]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Iota-carrageenan extracted from red algae is a potent inhibitor of SARS‐CoV-2 ' 'infection in reconstituted human airway epithelia', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'Biochemistry and Biophysics Reports', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.bbrep.2021.101187', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2021 The Authors. Published by Elsevier B.V.', 'name': 'copyright', 'label': 'Copyright'}], 'article-number': '101187'}